Jill Cottel, MD - Treatment of Chronic Pain in a Free Clinic Setting (2019 Conference) (LDN, low dose naltrexone)

Ted Cole, DO - The Use of LDN and Amino Acids in Parkinson's Disease (2019 Conference) (LDN, low dose naltrexone)

Angus Dalgleish, MD - The role of LDN in cancer management (2019 Conference) (LDN, low dose naltrexone)

Olga Cortez, MD - LDN Use in Women's Health II (2019 Conference) (LDN, low dose naltrexone)

Olga Cortez, MD - LDN Use in Women's Health I (2019 Conference) (LDN, low dose naltrexone)

Carrie Jones, ND, MPH - LDN and Cellular Hypothyroidism: Why you can't convert T4 into T3 (2019 Conference) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Brian Udell, Low Dose Naltrexone - Key Ingredient in the biomedical treatment of Autism Spectrum Disorder.

Learn about autism, the epidemic, and how LDN fits into a comprehensive therapeutic protocol to allow healing to take place. 

Elizabeth Livengood, NMD - LDN and MDD: A Case Study - Treating Depression in Patients with Autoimmune Conditions (2019 Conference) (LDN, low dose naltrexone)

Armin Schwarzbach, PhD, MD - Infections in Cancer and Autoimmune Disorders II (2019 Conference) (LDN, low dose naltrexone)

Dr Akbar Khan's LDN 2019 Conference Presentation

Low Dose Naltrexone (LDN) vs. Chemotherapy: One “Unproven” Therapy Against Another?